Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,296 | 16 | 40.6% |
| Food and Beverage | $28,258 | 1,122 | 31.6% |
| Honoraria | $12,580 | 6 | 14.1% |
| Travel and Lodging | $9,952 | 26 | 11.1% |
| Consulting Fee | $2,000 | 1 | 2.2% |
| Education | $359.28 | 14 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $33,715 | 86 | $0 (2023) |
| CSL Behring | $15,473 | 29 | $0 (2019) |
| Medtronic Vascular, Inc. | $5,111 | 21 | $0 (2019) |
| EMD Serono, Inc. | $4,039 | 51 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $3,504 | 12 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $3,326 | 45 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $2,527 | 3 | $0 (2017) |
| Biogen, Inc. | $2,018 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,776 | 46 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,592 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,621 | 140 | CATALYST PHARMACEUTICALS, INC. ($406.48) |
| 2023 | $3,606 | 149 | Biogen, Inc. ($517.28) |
| 2022 | $2,800 | 127 | Janssen Pharmaceuticals, Inc ($421.92) |
| 2021 | $2,993 | 155 | Eisai Inc. ($329.52) |
| 2020 | $1,715 | 77 | PORTOLA PHARMACEUTICALS, LLC ($189.85) |
| 2019 | $6,703 | 147 | Medtronic Vascular, Inc. ($3,285) |
| 2018 | $23,804 | 164 | Janssen Pharmaceuticals, Inc ($9,785) |
| 2017 | $44,203 | 226 | Janssen Pharmaceuticals, Inc ($23,251) |
All Payment Transactions
1,185 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.87 | General |
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $105.36 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: EPILEPSY | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $34.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $46.61 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| 11/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Neurology | ||||||
| 11/01/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Immunology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $114.74 | General |
| Category: Rare Disease | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $7.72 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $7.20 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,802 | 2,508 | $912,415 | $467,558 |
| 2022 | 17 | 1,874 | 2,722 | $927,414 | $494,477 |
| 2021 | 18 | 1,972 | 2,840 | $969,190 | $563,165 |
| 2020 | 14 | 1,817 | 2,510 | $820,745 | $428,774 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 231 | 240 | $199,200 | $114,471 | 57.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 314 | 464 | $116,000 | $74,431 | 64.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 274 | 280 | $175,000 | $62,961 | 36.0% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 272 | 278 | $101,470 | $47,660 | 47.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 395 | $63,200 | $42,340 | 67.0% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Office | 2023 | 69 | 69 | $57,270 | $30,264 | 52.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 30 | 149 | $52,150 | $28,005 | 53.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 36 | 99 | $19,800 | $9,779 | 49.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 62 | $18,600 | $9,689 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 73 | $12,775 | $8,703 | 68.1% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 11 | 22 | $18,560 | $6,941 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $18,810 | $6,914 | 36.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 20 | 20 | $10,000 | $4,948 | 49.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 16 | 16 | $8,640 | $4,559 | 52.8% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 92 | 96 | $10,080 | $3,914 | 38.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 60 | 68 | $10,540 | $3,779 | 35.9% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 93 | 96 | $10,560 | $3,687 | 34.9% |
| 95721 | Measurement of brain wave activity (eeg), 37-60 hours with health care professional review and report | Office | 2023 | 11 | 11 | $4,400 | $2,085 | 47.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 15 | 18 | $3,960 | $1,697 | 42.9% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 11 | 14 | $1,400 | $730.24 | 52.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 193 | 193 | $158,165 | $92,825 | 58.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 374 | 500 | $125,000 | $81,849 | 65.5% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 258 | 259 | $161,875 | $59,607 | 36.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 138 | 584 | $93,440 | $54,035 | 57.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 56 | 269 | $94,150 | $51,950 | 55.2% |
About Dr. Harmeet Sachdev, MD
Dr. Harmeet Sachdev, MD is a Neurology healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023076361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harmeet Sachdev, MD has received a total of $89,445 in payments from pharmaceutical and medical device companies, with $3,621 received in 2024. These payments were reported across 1,185 transactions from 77 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,296).
As a Medicare-enrolled provider, Sachdev has provided services to 7,465 Medicare beneficiaries, totaling 10,580 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location San Jose, CA
- Active Since 05/03/2006
- Last Updated 04/21/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023076361
Products in Payments
- XARELTO (Drug) $33,064
- Kcentra (Biological) $15,360
- Rebif (Biological) $3,160
- ANDEXXA (Drug) $3,079
- COPAXONE (Drug) $2,648
- ELIQUIS (Drug) $2,527
- Fycompa (Drug) $1,283
- TYSABRI (Biological) $1,152
- Briviact (Drug) $955.27
- ANDEXXA (Biological) $709.99
- AUBAGIO (Drug) $693.81
- FYCOMPA (Drug) $627.12
- KESIMPTA (Drug) $604.08
- Ponvory (Drug) $557.50
- APTIOM (Drug) $490.60
- SOLIRIS (Drug) $476.32
- UPLIZNA (Drug) $443.41
- UBRELVY (Drug) $441.24
- MAYZENT (Drug) $420.62
- ZEPOSIA (Drug) $391.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Jose
Noor Sachdev, Md, MD
Neurology — Payments: $218,603
Said Ibrahimi, Md, MD
Neurology — Payments: $15,209
Dr. Raj Gupta, M.d, M.D
Neurology — Payments: $12,977
Mr. Akshay Shah, M.d, M.D
Neurology — Payments: $8,411
Dr. Angela Anagnos, M.d, M.D
Neurology — Payments: $7,809
Dr. Jennifer Choi, M.d, M.D
Neurology — Payments: $6,111